NCI-H1563 Cells

The NCI-H1563 cell line is derived from a human non-small cell lung carcinoma (NSCLC) and is part of the NCI-Navy Medical Oncology Branch collection. This cell line originates from a lung adenocarcinoma, a subtype of NSCLC, highlighting its utility in studying lung cancer pathogenesis and drug responses. It is a model for exploring cellular and molecular mechanisms of NSCLC, which constitutes a significant proportion of lung cancer cases worldwide. NCI-H1563 has been characterized extensively in genomic and proteomic studies, including tyrosine kinase signaling pathways, which are pivotal in lung cancer progression. It has been noted for its phosphotyrosine signaling profile, contributing to understanding activated receptor tyrosine kinases and non-receptor tyrosine kinases in NSCLC. Such pathways are key targets for precision therapies, emphasizing the importance of this cell line in translational cancer research. As part of a larger database of cancer cell lines, NCI-H1563 has also been utilized to analyze genetic mutations, copy number variations, and chromosomal alterations. It contributes to studies aimed at distinguishing driver mutations from passenger mutations in cancer genomics. These features make NCI-H1563 a valuable tool for identifying therapeutic targets, studying resistance mechanisms, and developing personalized treatment strategies for lung cancer. Lung cancer cell lines, Lung, Lung adenocarcinoma, Growth Conditions: Adherent, Biosafety level: BSL 1